Cerus Corporation Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Devices |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Cerus Corporation (CERS) holds an ST Score of 65.6 out of 100 (B), with its strongest factor being Growth (A+) and its weakest Financial Strength (C-). Analysts rate CERS Buy across 10 ratings with a $4.00 average price target (+0.6% vs the current $2.56).
- Strongest
- GrowthA+
- Weakest
- Financial StrengthC-
All factor grades
- GrowthA+
- ProfitabilityA-
- ForecastA-
- ValuationB
- MomentumB
- Financial StrengthC-
- Piotroski4/9
Contact
CERS stock: frequently asked questions
What is CERS's ST Score?
Cerus Corporation (CERS) has an ST Score of 65.6 out of 100, an overall grade of B. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is CERS a buy, sell, or hold?
Wall Street's consensus rating on CERS is Buy based on 10 analyst ratings. Our own ST Score grades it B (65.6/100). This is data, not investment advice — always do your own research.
What is CERS's valuation grade?
Cerus Corporation (CERS) earns a valuation grade of B, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is CERS's growth grade?
Cerus Corporation (CERS) earns a growth grade of A+, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is CERS's profitability grade?
Cerus Corporation (CERS) earns a profitability grade of A-, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is CERS's financial strength grade?
Cerus Corporation (CERS) earns a financial strength grade of C-, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for CERS?
The average analyst price target for Cerus Corporation (CERS) is $4.00 from 10 analysts, which is +0.6% versus the recent price of $2.56.
What is CERS's Piotroski score?
Cerus Corporation (CERS) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.